Assessment of Liver Disease in Cystic Fibrosis
Overview
Pulmonary Medicine
Authors
Affiliations
Liver disease in cystic fibrosis has many causes, with biliary fibrosis due to abnormal CFTR protein predominating. Assessment requires aetiology to be defined. Biliary fibrosis may progress to cirrhosis and portal hypertension, which although initially asymptomatic, may cause varices and splenomegaly. Monitoring progression includes clinical and ultrasound assessment with endoscopic assessment of varices for those at risk. Extrapolated primarily from longitudinal assessment of viral hepatitis in adults, non-invasive elastography has a potential role. Evidence is lacking to support intervention strategies, but ursodeoxycholic acid and ligation of varices are widely applied. Indication and timing of liver transplantation are not clearly defined. Multidisciplinary approach is needed to tailor assessment and guide management.
Scaffold-mediated liver regeneration: A comprehensive exploration of current advances.
Bhatt S S, Krishna Kumar J, Laya S, Thakur G, Nune M J Tissue Eng. 2024; 15:20417314241286092.
PMID: 39411269 PMC: 11475092. DOI: 10.1177/20417314241286092.
Type II Abernethy malformation with cystic fibrosis in a 12-year-old girl: A case report.
Zhang L, Liu X, Chen T, Xu Z, Yin H World J Clin Cases. 2023; 11(32):7865-7871.
PMID: 38073688 PMC: 10698423. DOI: 10.12998/wjcc.v11.i32.7865.
Rashidi M, Matour E, Beheshti Nasab H, Cheraghzadeh M, Shakerian E Iran Biomed J. 2023; 27(4):199-204.
PMID: 37598299 PMC: 10507286. DOI: 10.61186/ibj.3948.
Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study.
Shakerian E, Afarin R, Akbari R, Mohammadtaghvaei N Mol Biol Rep. 2022; 49(4):2839-2845.
PMID: 35067813 DOI: 10.1007/s11033-021-07097-z.
Saikosaponin-d alleviates hepatic fibrosis through regulating GPER1/autophagy signaling.
Chen Y, Que R, Zhang N, Lin L, Zhou M, Li Y Mol Biol Rep. 2021; 48(12):7853-7863.
PMID: 34714484 PMC: 8604865. DOI: 10.1007/s11033-021-06807-x.